COPD in Never-Smokers: BOLD Australia Study.

Journal Information

Full Title: Int J Chron Obstruct Pulmon Dis

Abbreviation: Int J Chron Obstruct Pulmon Dis

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Disclosure Guy B Marks has provided independent medical service on an advisory board for Astra Zeneca. Michael J Abramson holds investigator-initiated grants for unrelated research from Pfizer, GSK, Boehringer-Ingelheim and Sanofi and he has also conducted an unrelated consultancy for Sanofi. He has also received a speaker’s fee from GSK. The other authors declare no conflicts of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript or in the decision to publish the results. The other authors declare no conflicts of interest."

Evidence found in paper:

"This research was funded by the National Health and Medical Research Council (NHMRC) of Australia, grant number 457385 and supported by the Thoracic Society of Australia and New Zealand, The Robert Pierce Grant-in-Aid for Indigenous Lung Health (2010); Air Liquide, AstraZeneca; GlaxoSmithKline; and Boehringer Ingelheim (2005)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025